The Wall Street Journal shared a link
2024-11-26 09:54:39 -
WWW.WSJ.COM
Roche to Acquire Poseida Therapeutics in a Deal Worth Up to $1.5 Billion
The deal allows the pharmaceutical company to bring in house its current partner with the aim of developing cell therapies in oncology, immunology and neurology.
0 Comments 0 Shares 22 Views
Please log in to like, share and comment!
© 2024 CGShares English
English Arabic French Spanish Portuguese Deutsch Turkish Dutch Italiano Russian Romaian Portuguese (Brazil) Greek
Terms Privacy Directory